BioSpace News Archive

To better address the current challenges with the nation’s blood supply, AABB (Association for the Advancement of Blood & Biotherapies) is launching the Alliance for a Strong Blood Supply.

Yumanity Therapeutics, a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, announced the grant to two employees of non-statutory stock options for the purchase of up to an aggregate of 6,000 shares of Yumanity’s common stock.

Dental health is as important as taking care every other part of the body.

Dental irrigation, also known as oral irrigation, is used as an alternative for flossing in case of people with sensitive gums, diabetes, orthodontic appliances, or people who cannot tolerate flossing.

Endovascular procedures have gained increased traction in clinical practice, especially in acute ischemic strokes and for a wide range of aneurysm repair.

Asthma is an inflammatory disease of the airways of lungs which makes breathing difficult.

The transesophageal echocardiography market study by Fact.MR offers compelling insights into key growth drivers and restraints impacting the market through 2031.

Globally the consumption of meat and seafood has grown drastically in the past couple of years. People nowadays prefer eating meat, pork, fish, and other animal products on regular basis.

HUTCHMED Limited announces that it has initiated a Phase Ib/II study in China of HMPL-453, an investigational novel selective inhibitor targeting fibroblast growth factor receptors 1/2/3, in combination with chemotherapy or the anti-PD-1 therapy, toripalimab.

Clinical and Histological Results Signal Prolonged Effectiveness in the Treatment of Advanced Retinal Degenerative Diseases.